Testing effectiveness (Phase 2)Ended earlyNCT03721679What this trial is testingPoly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1Who this might be right forSolid Cancer Oncovir, Inc. 7
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Early research (Phase 1)Looking for participantsNCT05458219What this trial is testingA First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid TumorsWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumors Innovent Biologics (Suzhou) Co. Ltd. 470
Early research (Phase 1)Looking for participantsNCT06493864What this trial is testingBL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsWho this might be right forBreast CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 21
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)WithdrawnNCT04001101What this trial is testingAnti-PD-1 +/- RT for MSI-H Solid TumorsWho this might be right forMicrosatellite Instability HighMismatch Repair DeficiencyColorectal Cancer University of Colorado, Denver
Early research (Phase 1)Not Yet RecruitingNCT07827144What this trial is testingTest How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours)Who this might be right forSolid Tumours AIMEDBIO 90
Testing effectiveness (Phase 2)Looking for participantsNCT07488676What this trial is testingASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsWho this might be right forGastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 150
Early research (Phase 1)Looking for participantsNCT06418061What this trial is testingStudy of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid TumorsWho this might be right forUnresectableLocally Advanced or Metastatic Solid Tumors Innovent Biologics (Suzhou) Co. Ltd. 198
Early research (Phase 1)Active Not RecruitingNCT05311397What this trial is testingA166 in Patients With Advanced Solid Malignant TumorsWho this might be right forBreast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Early research (Phase 1)Study completedNCT00252889What this trial is testingDoxil Topotecan Doublet Cancer StudyWho this might be right forSmall Cell Lung CancerPancreatic CancerHead and Neck Cancer+2 more Christiana Care Health Services 20
Early research (Phase 1)Study completedNCT00049023What this trial is testingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more O'Dorisio, M S 27
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Early research (Phase 1)UnknownNCT00688116What this trial is testingStudy of STA-9090, Administered Twice-Weekly in Patients With Solid TumorsWho this might be right forSolid Tumors Synta Pharmaceuticals Corp. 45
Testing effectiveness (Phase 2)Looking for participantsNCT06244771What this trial is testingA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid TumorsWho this might be right forAdvanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more Frontier Medicines Corporation 403
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT01183663What this trial is testingLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)Who this might be right forAdvanced Cancers M.D. Anderson Cancer Center 180
Early research (Phase 1)Study completedNCT00058253What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forRecurrent Prostate CancerStage IV Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Looking for participantsNCT06209580What this trial is testingAMT-253 in Patients With Advanced Solid TumoursWho this might be right forMalignant MelanomaAdvanced Solid Tumors Multitude Therapeutics Inc. 96
Testing effectiveness (Phase 2)Ended earlyNCT05497453What this trial is testingEvaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC OncogeneWho this might be right forHepatocellular CarcinomaSolid TumorHepatocellular Carcinoma Non-resectable+4 more Omega Therapeutics 24